CureVac N.V.
A biopharmaceutical company developing mRNA-based medicines for a range of diseases.
CVAC | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- FRIEDRICH-MIESCHER-STRASSE 15, 72076 TUBINGEN
- Website:
- https://www.curevac.com/
- Sector:
- Manufacturing
Description
CureVac N.V. is a global biopharmaceutical company that develops transformative medicines based on messenger ribonucleic acid (mRNA). With over two decades of experience, the company leverages its proprietary mRNA technology platform to enable the human body to produce its own therapeutic proteins to fight a wide range of diseases. CureVac's clinical development pipeline is focused on creating prophylactic vaccines for infectious diseases, as well as therapies in oncology and for rare diseases. The company collaborates with partners to advance its portfolio of mRNA-based candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CureVac N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CureVac N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CureVac N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
